Evidence map›Paper›PMID 24502371›Full record

ArticleSubstance use & misuse2014

A perfect storm: crack cocaine, HSV-2, and HIV among non-injecting drug users in New York City.

Don C Des Jarlais, Courtney McKnight, Kamyar Arasteh, Jonathan Feelemyer, David C Perlman, Holly Hagan, Emily F Dauria, Hannah L F Cooper

Abstract read
In one paragraph

Article in Substance use & misuse, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Molecular investigation of HIV-1 cross-group transmissions during an outbreak among people who inject drugs (2011-2014) in Athens, Greece.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2018
    Article
  5. Article
  6. Dopamine Increases CD14Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2017
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Don C Des Jarlais1Beth Israel Medical Center, Baron Edmond de Rothschild Chemical Dependency Institute, New York, USA.
Courtney McKnight
Kamyar Arasteh
Jonathan Feelemyer
David C Perlman
Holly Hagan
Emily F Dauria
Hannah L F Cooper
Mount Sinai Beth Israel · USGeorgia Department of Public Health · USHaifa Medical Center · ILNew York University · US

Funding

Transdisciplinary Theoretical Svnthesis and Development CoreP30DA011041 · NIDA · NEW YORK UNIVERSITY · PI Holly Hagan · 1998 to 2026
$38.9M
Risk Factors for HIV/AIDS in Drug UsersR01DA003574 · NIDA · NEW YORK UNIVERSITY · PI DES JARLAIS, DON C, MCKNIGHT, COURTNEY · 1986 to 2025
$16.2M
NIDA NIH HHS 5 R01 DA 03574NIDA NIH HHS P30 DA011041NIDA NIH HHS R01 DA003574
6 · The paper itself

Abstract

Prevalence of human immunodeficiency virus (HIV) infection has reached 16% among non-injecting drug users (NIDU) in New York City, an unusually high prevalence for a predominantly heterosexual population that does not inject drugs. Using a long-term study (1983-2011, >7,000 subjects) among persons entering the Beth Israel drug-treatment programs in New York City, we identified factors that contributed to this high prevalence: a preexisting HIV epidemic among injectors, a crack cocaine epidemic, mixing between injectors and crack users, policy responses not centered on public health, and herpes-simplex virus 2 facilitating HIV transmission. Implications for avoiding high prevalence among NIDU in other areas are discussed.

Indexed as

Crack CocaineHealth PolicySexual BehaviorCocaine-Related DisordersCoinfectionDrug UsersFemaleHerpes SimplexHerpesvirus 2, HumanHIV InfectionsHumansLongitudinal StudiesMaleNew York CityPrevalenceRisk FactorsCrack Cocaine

Identifiers

PMID24502371
PMCPMC4451113
OpenAlexW2163754363

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.